undefined

Giuseppe Curigliano

Professor of oncology at the European Institute of Oncology in Milan who contributes international clinical trial experience and perspectives on PI3K/AKT/PTEN–targeted therapies.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app